ITGAX and neoplasm: To further investigate the immune-cell-dependent contribution to antitumour immunity, we evaluated tumour growth inhibition by antibody blockade of CD8 T cells, NK cells and in CD11c-DTR transgenic mice with depletion of DCs49.